Please login to the form below

Celgene wins expanded EU approval for cancer drug Revlimid

Approved for use in patients with rare blood disorder

Rare diseases drug company will move to new US site in 2015

Becomes first contraceptive of its kind to reach the UK market

Builds on existing cancer/ cholesterol alliance between pharma companies

Marks drug's first approval to treat newly diagnosed glioblastoma

US approval provides alternative to surgery for use in giant cell tumour of the bone

US Supreme Court decides genes can be patented, if synthetically produced

Will pay $2.15bn in landmark patent infringement lawsuit

Institute not recommending Lilly’s lung cancer drug for new licence extension

Building pharma brands driven by customer-focused innovation will enable companies to differentiate their products in a crowded marketplace

A look back at Sanofi's merger with Synthélabo

This month, in 1999: How two pharma companies came together to create a giant
Lifestyle choices of consumer health

A race has emerged between pharma and the consumer goods industries to stake claims on the consumer health market

Alcon wins initial NICE backing for Jetrea in rare eye condition

Would be first alternative to surgery available to vitreomacular traction patients in England and Wales
PMEA 2013 opens for entry

Programme recognises responsible marketing and business practice in the healthcare industry
BMS' Orencia matches Humira in arthritis study

Data should help drug establish itself against AbbVie's market-leading RA medicine
France investigates Teva after packaging mix-up

Some packages of diuretic furosemide found to contain sleeping pill zopiclone
NICE U-turn on GSK's Revolade

Watchdog says yes to blood disorder drug three years after initial knockback
New formulations of Pralia and Enbrel head list of new drugs in Japan

Regulator backs medicines from Pfizer, Takeda, Daiichi Sankyo, Astellas, Zeria and otsuka
FDA approves Sanofi's four-in-one flu vaccine

But wants more safety data for hepatitis B vaccine from Dynavax

Amgen veteran Kurt Gustafson joins Spectrum as CFO

Biotech also creates new senior financial position for Brett Scott
Alexza’s Peter Schineller joins Agendia

Appointed first chief commercial officer
Allergan veteran joins Kala as head of business development

Charles McDermott has experience in ophthalmology
Sanofi hires David Loew from Roche

Will head commercial operations in Europe
New chief information officer at Bayer Healthcare

Promotion for Johannes Schubmehl

Head of Commercial Training Strategy (m/ f): On application
Marketing Manager - Pharmaceuticals, Northern UK: Excellent Salary & Benefits
UK Marketing Director: 80,000 to 100,000 per annum
Medical Writer / Editor – LONDON: DOE

Add my company

At Munro & Forster we deliver real and lasting impact for our clients.We specialise in health and wellbeing, education ...

What IF (Indigenus Forum) Meeting Report: IFs (Indigenus Forums) are a series of invite-only events hosted by Indigenus agencies that bring top thought leaders together to help solve some of our industry’s most pressing challenges. ...
Developing multichannel capability in Pharma: Understanding your customers' needs is only half of the multichannel challenge; you must also have the business capability to deliver on your objectives. Find out how training could give your ...
Deal Watch table for May 2013: Table listing all the major pharma mergers, acquisitions and collaborations in the past month...